Arixtra (fondaparinux sodium) is an anticoagulant (blood thinner) used to prevent and treat serious blood clot conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE). It is also used post-surgery to reduce the risk of clot formation in patients undergoing orthopedic or abdominal procedures.

Administered as a once-daily subcutaneous injection, Arixtra works by inhibiting Factor Xa, an enzyme involved in the clotting process, making it highly effective at reducing clot risk without the need for regular blood monitoring like warfarin.

Alternative Medications & Equivalents:

• Lovenox (enoxaparin) – Low molecular weight heparin with similar uses
• Xarelto (rivaroxaban) – Oral Factor Xa inhibitor (pill alternative)
• Eliquis (apixaban) – Oral blood thinner for stroke and clot prevention
• Heparin – Short-acting injectable anticoagulant used in hospital settings
• Generic Fondaparinux – Cost-effective equivalent available in some regions

Treatment selection depends on clinical setting, renal function, bleeding risk, and patient preference.

Key Benefits:

• Prevents and treats DVT and PE
• Recommended post-surgery to reduce clotting risks
• Convenient once-daily injection
• Does not require routine blood test monitoring
• Available as Arixtra and generic fondaparinux
• Shipped securely and temperature-controlled by MailOrderMeds

Important Note:

Arixtra is a prescription-only injectable medication. Must be administered exactly as directed. Not suitable for patients with active bleeding, low platelet count, or severe kidney impairment.